Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    An addition of Revision: v3.4.2 and a deletion of Revision: v3.4.1 were made in the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:23:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; there are no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:32:56.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary option and updated versioning/QC labels, including Last Update Submitted that Met QC Criteria and a new Revision: v3.4.0, with minor capitalization changes such as No FEAR Act Data.
    Difference
    0.2%
    Check dated 2026-01-28T06:31:14.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A minor revision tag v3.3.4 was added and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:18:26.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added Locations section with Massachusetts and New York sites and updated the page revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:40:52.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Updated the page to Revision: v3.3.2, replacing the previous v3.2.0. No core study information or documents were visibly changed.
    Difference
    0.1%
    Check dated 2025-11-25T11:23:58.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.